Stock comparison
DEXCOM INC is 17.8x more valuable than LEMAITRE VASCULAR INC by market capitalization ($32.33 B vs $1.82 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
DEXCOM INC is 17.8x more valuable than LEMAITRE VASCULAR INC by market capitalization ($32.33 B vs $1.82 B).
Market value leader
DXCM
DEXCOM INC is 17.8x more valuable than LEMAITRE VASCULAR INC by market capitalization ($32.33 B vs $1.82 B).
Revenue leader
DXCM
LMAT: $249.60M vs DXCM: $4.66B.
Profit leader
DXCM
LMAT: $57.70M vs DXCM: $836.30M.
Margin leader
LMAT
LMAT: 23.1% vs DXCM: 17.9% net margin.
| Metric | LMAT | DXCM |
|---|---|---|
| Market cap | $1.82 B | $32.33 B |
| US-listed rank | #2203 | #445 |
| Revenue (latest FY) | $249.60M | $4.66B |
| Net income (latest FY) | $57.70M | $836.30M |
| Net margin | 23.1% | 17.9% |
| P/E (trailing FY) | 31.5x | 38.7x |
| SEC filings | 1,849 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
DEXCOM INC is 17.8x more valuable than LEMAITRE VASCULAR INC by market capitalization ($32.33 B vs $1.82 B).
In their latest fiscal years, LEMAITRE VASCULAR INC reported $249.60M in revenue while DEXCOM INC reported $4.66B.
Full pages: LEMAITRE VASCULAR INC and DEXCOM INC, or browse the full rankings.